News and Events
The Research!America alliance advocates for science, discovery, and innovation to achieve better health for all.
“We need to use science to make actions into solutions,” said Dr. Robert Redfield, Director, U.S. Centers for Disease Control, as part of his opening remarks at Research!America’s Straight Talk: National Health Research Forum. At the Forum, held at the Conrad Washington, D.C. on September 5, 2019, panelists reflected on the challenges and achievements of the past 30 years, as Research!America marked our 30th anniversary and were inspired to take next steps to maximize the power of science and data to improve health.
The day's events also featured an all-women's panel where leading researchers reflected on career paths, challenges, and successes; a look at the importance of collaboration in catalyzing progress; and a look at the power of data to transform health care.
The closing remarks were delivered by Dr. Ned Sharpless, Acting Commissioner of the Food and Drug Administration.
“We have a moral responsibility to fund research because it saves lives,” declared Speaker of the House, U.S. Representative Nancy Pelosi, in her remarks congratulating the honorees at the Research!America 2019 Advocacy Awards dinner. “Tonight we thank all of you- this room full of dreamers, dreamers with a plan... it’s not just about research, it’s about a healthier America, a healthier world.”
Speaker Pelosi joined many leaders in research advocacy in celebrating Research!America’s 30th anniversary at the event, held at the Andrew W. Mellon Auditorium in Washington, D.C. on March 13, 2019.
Research is making a difference in the lives of thousands of people with rare diseases, but there is room for more to be done, as the featured guests discussed at Research!America’s reception event, “Rare Diseases: Perspectives on Progress.” The reception, held February 26, 2019, at the Washington Court Hotel, featured a panel of powerful advocates who highlighted the importance of research in improving lives.
Research!America CEO and President Mary Woolley moderated a panel during the event, which took place during Rare Disease Week, a program of the EveryLife Foundation for Rare Diseases. “There are 7000 rare diseases,” she said in her opening remarks, “and only 5% have FDA-approved treatments. That’s not only not good enough, that’s unacceptable.”
Even as dozens of elections across the nation remained undecided or subject to recounts, it was clear that a divided Congress – and a divided nation – would have a significant impact on the future of medical and scientific research. Research!America’s Post-Election Briefing on November 8, at the American Association for the Advancement of Science (AAAS) in Washington, D.C. featured distinguished scientists and research advocates who to discussed the impact of the election and ways to advance research and development (R&D).